• 下载App


  • 在线客服

成功领取价值超 5000港元/年的高级行情
前往体验 >>

Pure Extracts Reaches 36 Product SKU Listings Across Canada

GlobeNewswire ·  {{timeTz}}

VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) ("Pure Extracts" or the "Company"), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that it has reached a total of 36 product SKUs in its provincial listings across Canada.


The product mix includes 17 Pure Pulls vape SKUs and 19 Pure Chews edible gummie SKUs for sale in licensed dispensaries in British Columbia, Alberta, Saskatchewan, Ontario and New Brunswick as well as on the Abba Medix national medical platform. 

产品组合包括17个Pure Pull Vape SKU和19个Pure Chews食用口香糖SKU,在不列颠哥伦比亚省、艾伯塔省、萨斯喀彻温省、安大略省和新不伦瑞克的特许药房以及Abba Medex国家医疗平台上销售。

The next product launch will be a Pure Pulls 1 gram, high-potency THC, terpene-infused, distillate vape cart that will provide recreational consumers with a powerful and flavourful smoking experience.

下一次推出的产品将是Pure Pull 1克,高效THC,注入萜烯的馏分蒸汽车,将为休闲消费者提供强大和美味的吸烟体验。

Pure Extracts CEO, Ben Nikolaevsky, remarked, "We are pleased to see our brands' acceptance steadily growing across the country and I believe that our new high-potency vape carts will be a high-volume SKU that generates material revenue for our vape division."

PURE EXTRACTS首席执行官Ben Nikolaevsky表示:“我们很高兴看到我们的品牌在全国范围内的接受度稳步上升,我相信我们新的高效能Vape购物车将是一个高产量的SKU,为我们的Vape部门带来可观的收入。”

"Ben Nikolaevsky"
Ben Nikolaevsky
CEO and Director


About Pure Extracts (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)


Pure Extracts Technology Corp. features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act on September 25, 2020, and its Sales Amendment on July 19, 2021. The Company's stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.


Find out more at


Or contact:
Pure Extracts Investor Relations
Tel: +1 604 493 2052

电话:+1 604 493 2052

This news release contains forward-looking statements relating to the future operations of Pure Extracts, and the other statements are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Pure Extracts', are forward-looking statements and involve risks and uncertainties. A number of factors could cause actual events, performance or results to differ materially from what is projected in forward looking statements. Although we believe that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and we cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements. Whether actual results, performance or achievements will conform to the Company's expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under "Risk Factors" in the Company's Annual Information Form. The Company does not undertake to update any forward-looking information, except as, and to the extent required by, applicable securities laws.

本新闻稿包含与Pure Extras未来运营有关的前瞻性陈述,其他陈述不是历史事实。前瞻性陈述通常用“将”、“可能”、“应该”、“预期”、“预期”和类似的表达方式来识别。除历史事实陈述外,本新闻稿中包含的所有陈述,包括但不限于有关Pure Extras未来计划和目标的陈述,均为前瞻性陈述,涉及风险和不确定因素。许多因素可能导致实际事件、业绩或结果与前瞻性陈述中预测的大不相同。尽管我们认为这些陈述背后的假设是合理的,但它们可能被证明是不正确的,我们不能保证实际结果将与这些前瞻性陈述一致。鉴于这些风险、不确定性和假设,投资者不应过度依赖这些前瞻性陈述。无论实际结果、业绩或成就是否符合公司的预期和预测,都会受到许多已知和未知的风险、不确定性、假设和其他因素的影响,包括公司年度信息表格中“风险因素”中列出的那些因素。公司不承诺更新任何前瞻性信息,除非适用的证券法要求更新。

The CSE has neither approved nor disapproved the contents of this press release.